Kate Schroder

Professor Kate Schroder is a Group Leader at the Institute for Molecular Bioscience (IMB), University of Queensland. Her research focuses on inflammasome biology, investigating their role in immune defense and inflammatory diseases such as gout, diabetes, neurodegeneration, and cancer. Her lab explores inflammasome activation mechanisms, inhibition strategies, and their function in neutrophils and human-specific pathways. She is an NHMRC Leadership Fellow and collaborates with institutions globally.

Research interests include inflammasome-caspase interactions, neutrophil signaling, host-pathogen interactions, and human-specific inflammasome pathways. She leads a team of researchers and students, advancing therapeutic approaches targeting inflammasomes for inflammatory diseases. Key projects involve small-molecule inhibitors (e.g., MCC950) and CRISPR-based human cell studies.

• Awards: NHMRC Leadership Fellow
• Collaborators: Includes Prof Matthew Sweet, Jenny Stow, and international partners like Trinity College Dublin and University of New Mexico.

Publications emphasize inflammasome structure-function relationships, therapeutic inhibition, and disease mechanisms. Her work bridges basic science and translational medicine, with implications for neurodegenerative and infectious diseases.